Tahir Mahmood is the founder of Applied Molecular Transport. Applied Molecular Transport has raised $154M in total funding.
Tahir Mahmood is associated with Applied Molecular Transport. The company focuses on developing novel, oral biological therapeutics to treat severe autoimmune, metabolic, and inflammatory diseases. Applied Molecular Transport was acquired by Cyclo Therapeutics.
Full founder directory · Investor directory · Company funding database · Fundraising library